Rasalect 0.5 Tablet is a medicine used to treat Parkinson's disease. It helps to provide better control of body movements and prevents excessive shaking and stiffness.

Soluble insulin is a short-acting insulin. It is used to reduce high blood sugar levels after a meal in patients with diabetes mellitus.

Actrapid Hm Penfill Injection Human insulin (100IU) ₹ 350/Piece Enter Quantity Piece Submit Requirement composition Human insulin (100IU) package type 3ml PENFILL INJECTION DELIVERY WITHIN 10 DAYS WORLDWIDE treatment Diabetes brand name Actrapid HM 100IU/ml Penfill company Novo Nordisk India Pvt Ltd Actrapid HM 100IU/ml Penfill is a short-acting insulin used to treat type 1 and type 2 diabetes mellitus. It is used together with a healthy diet and regular exercise to control blood sugar levels after meals. This helps to prevent serious complications of diabetes like kidney damage and blindness. Actrapid HM 100IU/ml Penfill is normally prescribed along with a long-acting type of insulin or other diabetes medicines. Your doctor or nurse will teach you the correct way of injecting it under the skin. It should be taken 20-30 minutes before a meal. Do not stop taking it unless your doctor tells you to. It is only a part of the treatment program that should also include a healthy diet, regular exercise, and weight reduction as advised by your doctor

Empagliflozin is used to treat type 2 diabetes. It works in the kidneys to prevent absorption of glucose (blood sugar). This helps lower the blood sugar level. Empagliflozin does not help patients who have insulin-dependent or type 1 diabetes.

It is used for the treatment of Type II Diabetes. Type II Diabetes Mellitus is a serious condition wherein the body doesn't use insulin effectively, which causes unusual blood glucose levels (either not creating enough insulin, or the insulin they do make does not accomplish its purpose in the body).

Dapasmart-Trio 500 mg Tablet 10's is an antidiabetic medicine used to treat diabetes. It is used for the treatment of Type II Diabetes. Type II Diabetes Mellitus is a serious condition wherein the body doesn't use insulin effectively, which causes unusual blood glucose levels (either not creating enough insulin, or the insulin they do make does not accomplish its purpose in the body).

Hirepa 1 mg Tablet is used to lower blood sugar levels in adults with type 2 diabetes mellitus. It is usually prescribed along with other diabetes medicines to achieve adequate blood sugar control. It also prevents serious complications of diabetes like kidney damage and blindness.Uses of Hirepa TabletTreatment of Type 2 diabetes mellitusIn Treatment of Type 2 diabetes mellitusHirepa 1 mg Tablet increases the amount of insulin your body produces (in the pancreas). The insulin then works to lower your blood glucose levels and prevents them from rising after taking meals.

GLISAXAPIN M 2.5/500 is used to treat type 2 diabetes by combining Saxagliptin (2.5mg) and Metformin HCI (ER) (500mg). Saxagliptin enhances the action of incretin hormones to increase insulin release and reduce glucagon, while Metformin decreases glucose production in the liver and improves insulin sensitivity.

Rybelsus Semaglutide 3 Mg exporter in India Best Price Rs 2,800 / StripePrice on Request Product Brochure Form Tablets Packaging Type Strip Manufacturer NOVO NORDISK INDIA PVT LTD strength 3 mg Brand Rybelsus Rybelsus Semaglutide 3mg Tablet is a medicine used to lower blood sugar levels in adults with type 2 diabetes mellitus. Rybelsus Semaglutidehelps prevent serious complications of diabetes like kidney damage and blindness. Rybelsus Semaglutide works by helping the body produce insulin and reducing appetite. It also helps reduce weight in some people. We export Rybelsus Semaglutide tablets to USA ,UK , EUROPE, AUSTARILA, JAPAN ,KOREA ,CHINA & all over the world “As Novo Nordisk marks 100 years of commitment and innovation in diabetes care, Rybelsus® remains a pivotal part of our portfolio, making history as the first oral GLP-1 receptor agonist and helping to fuel our mission to improve the lives and health of people living with diabetes.“